Tissue glucocorticoid sensitivity: Beyond stochastic regulation on the diverse actions of glucocorticoids

被引:38
作者
Kino, T. [1 ]
机构
[1] Natl Inst Child Hlth & Human Dev, Reprod Biol & Med Branch, Pediat Endocrinol Sect, NIH, Bethesda, MD 20892 USA
关键词
tissue glucocorticoid sensitivity; glucocorticoid receptor; cyclin-dependent kinase 5;
D O I
10.1055/s-2007-980193
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Glucocorticoids have a broad array of life-sustaining functions, such as for the maintenance of the basal- and stress-related organ homeostasis. They are also frequently used as therapeutic compounds for many pathologic conditions. Thus, changes of tissue sensitivity to glucocorticoids play important roles in the physiologic conditions and are associated with and influence the course of numerous pathologic states. Changes in tissue glucocorticoid sensitivity may present on either side of an optimal range, respectively as glucocorticoid resistance or hypersensitivity, and may be generalized or tissue-specific. Recent insights into the mechanisms of the glucocorticoid receptor (GR) action indicated that the glu-cocorticoid signaling system is highly stochastic. Indeed, numerous factors contribute to the hormonal action at each step of the GR signaling cascade, such as ligand availability, receptor isoform expression, intracellular circulation, promoter association, attraction of cofactors, and finally clearance of the receptor from the target genes. Importantly, these regulatory mechanisms appear to be functional in tissue-, gene- and cellular biologic state-specific fashions. As an example of such phase-specific factors, we discussed influence of the cyclin-dependent kinase 5 to the GR transcriptional activity, which specifically functions in the central nervous system and may thus play an important role in the regulation of glucocorticoid action in this organ.
引用
收藏
页码:420 / 424
页数:5
相关论文
共 43 条
[1]   Hyperphosphorylated tan and neurofilament and cytoskeletal disruptions in mice overexpressing human p25, an activator of cdk5 [J].
Ahlijanian, MK ;
Barrezueta, NX ;
Williams, RD ;
Jakowski, A ;
Kowsz, KP ;
McCarthy, S ;
Coskran, T ;
Carlo, A ;
Seymour, PA ;
Burkhardt, JE ;
Nelson, RB ;
McNeish, JD .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (06) :2910-2915
[2]  
[Anonymous], 2001, ENDOCRINOLOGY METABO
[3]  
[Anonymous], TXB ENDOCRINOLOGY
[4]  
[Anonymous], HDB STRESS BRAIN
[5]   GLUCOCORTICOID RECEPTOR-BETA, A POTENTIAL ENDOGENOUS INHIBITOR OF GLUCOCORTICOID ACTION IN HUMANS [J].
BAMBERGER, CM ;
BAMBERGER, AM ;
DECASTRO, M ;
CHROUSOS, GP .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 95 (06) :2435-2441
[6]  
Chrousos G.P., 2001, ENDOCRINOLOGY METABO, V4th ed., P609
[7]   The role of stress and the hypothalamic-pituitary-adrenal axis in the pathogenesis of the metabolic syndrome: neuro-endocrine and target tissue-related causes [J].
Chrousos, GP .
INTERNATIONAL JOURNAL OF OBESITY, 2000, 24 (Suppl 2) :S50-S55
[8]   SEMINARS IN MEDICINE OF THE BETH-ISRAEL-HOSPITAL, BOSTON - THE HYPOTHALAMIC-PITUITARY-ADRENAL AXIS AND IMMUNE-MEDIATED INFLAMMATION [J].
CHROUSOS, GP .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (20) :1351-1362
[9]   The glucocorticoid receptor and the orphan nuclear receptor chicken ovalbumin upstream promoter-transcription factor II interact with and mutually affect each other's transcriptional activities: Implications for intermediary metabolism [J].
De Martino, MU ;
Bhattachryya, N ;
Alesci, S ;
Ichijo, T ;
Chrousos, GP ;
Kino, T .
MOLECULAR ENDOCRINOLOGY, 2004, 18 (04) :820-833
[10]   A decade of CDK5 [J].
Dhavan, R ;
Tsai, LH .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2001, 2 (10) :749-759